E. T. et al., The effect of
exercise-training on resting metabolic rate in lean and moderately obese
individuals. Int. J. Obes. 1986 10 511-517.
227. Valtuena S; Blanch S; Barenys M; Sola R; Salas-Salvado J Changes in
body composition and resting energy expenditure after rapid weight loss: is
there an energy-metabolism adaptation in obese patients? Int J Obes Relat
Metab Disord 1995 Feb;19(2):119-25
228. van Baak MA Exercise training and substrate utilisation in obesity.
Int J Obes Relat Metab Disord 1999 Apr;23 Suppl 3:S11-7
229. Vander Tuig JG, Beneke WM Low-protein diet blocks development of
hyperphagia and obesity in rats with hypothalamic knife cuts. J Nutr 1996
Jun;126(6):1713-21
230. Vara L., Agras S Caloric intake and activity levels are related in
yong children Int. J. Obes. 1989 13 613-617.
231. Viru A., Smirnova T. Health promotion and exercise training //
Sports Med. - 1995. - Vol. 19. - P. 123-136.
232. Wannamathee G., Shaper A. G. Weight change in middle-aged British
men: implications for health. Eur. J. Clin. Nutr. 1989 44 133-142
233. Weissman NJ, Tighe JF Jr, Gottdiener JS, Gwynne JT Prevalence of
valvular-regurgitation associated with dexfenfluramine three to five months
after discontinuation of treatment. J Am Coll Cardiol 1999 Dec;34(7):2088-95
234. Wells JC Is obesity really due to high energy intake or low energy
expenditure? Int J Obes Relat Metab Disord 1998 Nov;22(11):1139-40
235. Weyer C, Snitker S, Rising R, Bogardus C, Ravussin E Determinants of
energy expenditure and fuel utilization in man: effects of body composition,
age, sex, ethnicity and glucose tolerance in 916 subjects. Int J Obes Relat
Metab Disord 1999 Jul;23(7):715-22
236. Wilkinson P. W., Parkin J. M., Pearlson G. et al., Energy intake and
physical activity in obese children. Br. Med. J. 1977, i 756
237. Willett WC Is dietary fat a major determinant of body fat? Am J Clin
Nutr 1998;67:556S-562S.
238. Williams KV, Mullen ML, Kelley DE, Wing RR The effect of short
periods of caloric restriction on weight loss and glycemic control in type 2
diabetes. Diabetes Care 1998 Jan;21(1):2-8
239. Wilmore JH Increasing physical activity: alterations in body mass
and composition. Am J Clin Nutr 1996 Mar;63(3 Suppl):456S-460S
240. Wing RR. Use of very-low-calorie diets in the treatment of obese
persons with non-insulin-dependent diabetes mellitus. J Am Diet Assoc 1995
May;95(5):569-72; quiz 573-4
241. Wolf A. M.; Colditz G. A. Social and economic effects of body weight
in the United States. Am. J. Clin. Nutr. 1996. - V. 63., N3. (Suppl). - P.
466S-469S
242. Wong J, Reddy SS, Klein AL Anorectic drugs and valvular heart
disease: a biological and clinical perspective. Cleve Clin J Med 1998
Jan;65(1):35-41
243. Wurtman J, Wurtman R, Reynolds S et al., D-fenfluramine supresses
snack intake among carbohydrate cravers but not among non-carbohydrate
cravers. Inter. J. Eat. Disord.- 1987. - V.6.,N8. - P. 687-699.
244. Yamanouchi K; Shinozaki T; Chikada K; Nishikawa T; Ito K; Shimizu S;
Ozawa N; Suzuki Y; Maeno H; Kato K; et al., Daily walking combined with diet
therapy is a useful means for obese NIDDM patients not only to reduce body
weight but also to improve insulin sensitivity. Diabetes Care 1995
Jun;18(6):775-8
245. Yki-Jarvinen H, Nikkila K, Makimattila S Metformin prevents weight
gain by reducing dietary intake during insulin therapy in patients with type
2 diabetes mellitus. Drugs 1999;58 Suppl 1:53-4; discussion 75-82
246. Zhi J., Melia A. T., Guerciolini R., et al., Retrospective
population-based analysis of the dose-response (fecal fat excretion)
relationship of orlistat in normal and obese volunteers. Clin Pharmacol.
Ther. 1994 56 82-85].
247. Zhi J; Melia AT; Eggers H; Joly R; Patel IH Review of limited
systemic absorption of orlistat, a lipase inhibitor, in healthy human
volunteers. J Clin Pharmacol 1995 Nov;35(11):1103-8].
248. Zimmet P, Collier G Clinical efficacy of metformin against insulin
resistance parameters: sinking the iceberg. Drugs 1999;58 Suppl 1:21-8;
discussion